Danaher to Acquire Iris International for $338M | GenomeWeb

NEW YORK (GenomeWeb News) – Danaher today said that it has signed definitive agreement to acquire diagnostics and sample prep technologies firm Iris International for $19.50 per share in cash.

The total consideration being paid is $338 million including debt and net of cash acquired, said Danaher. The purchase price represents a 45 percent premium to Iris' closing stock price of $13.42 on Sept. 14.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.